| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Division of Endocrinology, Clinical Nutrition, and Vascular Medicine, Department of Internal Medicine, University of California, Davis, Davis, CA 95616; Division of Endocrinology, Metabolism, and Molecular Medicine, Northwestern University, Feinberg School of Medicine, Chicago, IL 60611; Department of Psychiatry and Psychology, University of Illinois at Chicago, Chicago, IL 60612; Molecular Cardiology Research Institute, Department of Medicine, and Division of Cardiology, New England Medical Center Hospitals and Tufts University School of Medicine, Boston, MA 02111; Departments of Physiology and Biophysics, and Biology, University of Washington, Seattle, WA 98195
* To whom correspondence should be addressed. E-mail: jlturgeon{at}ucdavis.edu.
Recent publications describing the results of the Women's Health Initiative (WHI) and other studies reporting the impact of hormone therapy on aging women have spurred re-examination of the broad use of estrogens and progestins during the postmenopausal years. Here we review the complex pharmacology of these hormones, the diverse and sometimes opposite effects that result from the use of different estrogenic and progestinic compounds, given via different delivery routes, in different concentrations and treatment sequence, and to women of different ages and health status. We examine our new and growing appreciation of the role of estrogens in the immune system and the inflammatory response and pose the concept that estrogen's interface with this system may be at the core of some of the effects on multiple other physiological systems, such as the adipose/metabolic system, the cardiovascular system, and the central nervous system. We compare and contrast clinical and basic science studies as we focus on the actions of estrogens in these systems since the untoward effects of hormone therapy reported in the WHI were not expected. The broad interpretation and publicity of the results of the WHI has resulted in a general condemnation of all hormone replacement in postmenopausal women. In fact, careful review of the extensive literature suggests that data resulting from the WHI and other recent studies should be interpreted within the narrow context of the study design. We argue that these results should encourage us to perform new studies that take advantage of a dialogue between basic scientists and clinician scientists to ensure appropriate design, incorporation of current knowledge, and proper interpretation of results. Only then will we have a better understanding of what hormonal compounds should be used in which populations of women and at what stages of menopausal/postmenopausal life.
This article has been cited by other articles:
 |
|
 |
|
  A. M. Etgen Estrogens and Alzheimer's Disease: Is Cholesterol a Link? Endocrinology, September 1, 2008; 149(9): 4253 - 4255. [Full Text] [PDF]
|
|
|
|
|
|
P. Luciani, C. Deledda, F. Rosati, S. Benvenuti, I. Cellai, F. Dichiara, M. Morello, G. B. Vannelli, G. Danza, M. Serio, et al. Seladin-1 Is a Fundamental Mediator of the Neuroprotective Effects of Estrogen in Human Neuroblast Long-Term Cell Cultures Endocrinology, September 1, 2008; 149(9): 4256 - 4266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Otto, I. Fuchs, H. Altmann, M. Klewer, A. Walter, K. Prelle, R. Vonk, and K.-H. Fritzemeier Comparative Analysis of the Uterine and Mammary Gland Effects of Drospirenone and Medroxyprogesterone Acetate Endocrinology, August 1, 2008; 149(8): 3952 - 3959. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. E. Hjerrild, K. H. Mortensen, and C. H. Gravholt Turner syndrome and clinical treatment Br. Med. Bull., June 1, 2008; 86(1): 77 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Vitale, G. Mercuro, E. Cerquetani, G. Marazzi, R. Patrizi, F. Pelliccia, M. Volterrani, M. Fini, P. Collins, and G. M.C. Rosano Time Since Menopause Influences the Acute and Chronic Effect of Estrogens on Endothelial Function Arterioscler. Thromb. Vasc. Biol., February 1, 2008; 28(2): 348 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M MacKenzie, D. Dewar, W. Stewart, R. Fraser, J. M C Connell, and E. Davies The transcription of steroidogenic genes in the human cerebellum and hippocampus: a comparative survey of normal and Alzheimer's tissue J. Endocrinol., January 1, 2008; 196(1): 123 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L. McCarthy, R. B. Hochberg, D. C. Labaree, and M. Centrella 3-Ketosteroid Reductase Activity and Expression by Fetal Rat Osteoblasts J. Biol. Chem., November 23, 2007; 282(47): 34003 - 34012. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Suzuki, C. M. Brown, C. D. Dela Cruz, E. Yang, D. A. Bridwell, and P. M. Wise Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions PNAS, April 3, 2007; 104(14): 6013 - 6018. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Alevizaki, K Saltiki, A Cimponeriu, I Kanakakis, N Xita, C C Alevizaki, I Georgiou, and H-L Sarika Severity of cardiovascular disease in postmenopausal women: associations with common estrogen receptor {alpha} polymorphic variants Eur. J. Endocrinol., April 1, 2007; 156(4): 489 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Wierman Sex steroid effects at target tissues: mechanisms of action Advan Physiol Educ, March 1, 2007; 31(1): 26 - 33. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
